drugset / Trial / NCT01137747
Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is to test escalating doses of carfilzomib in patients with relapsed acute myeloid and acute lymphoblastic leukemia.
Timeline
- Start
- 2010-10
- Primary completion
- 2014-08
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carfilzomib | Other / unclassified | 36 mg/m2 | Intravenous |
| Subject | Carfilzomib | Other / unclassified | 45 mg/m2 | Intravenous |
| Subject | Carfilzomib | Other / unclassified | 56 mg/m2 | Intravenous |